UPClytics
EnglishDeutsch
Sign inSign up
View all cases

UPC CFI 2822/2026

Aug 5, 2026·EP2401365: REENGINEERING MRNA PRIMARY STRUCTURE FOR ENHANCED PROTEIN PRODUCTION

Follow
Case details
Status
Written Phase
Action
Other
Category
Other Procedural
Parties
Respondents
Representatives
  • Georg Rauh
Division
Munich LD
Judges
Technology
Biotechnology
Language
English
Documents
Document titleDatePublic
action.publishOrderDecision.case2026-09-09Not public
Receipt2026-09-03Not public
Cover sheet2026-09-03Not public
Document2026-09-03Not public
action.communication.general2026-09-02Not public
Receipt2026-09-01Not public
Cover sheet2026-09-01Not public
Other document Applicant2026-09-01Not public
Receipt2026-09-01Not public
Cover sheet2026-09-01Not public
Document2026-09-01Not public
Receipt2026-08-05Not public
Cover sheet2026-08-05Not public
Application document Applicant2026-08-05Not public
Other cases on the same patent
Other cases involving the same parties
  • 2026-07-16UPC CFI 2562/2026Genevant Sciences GmbH v Pfizer, Inc.
  • 2026-07-16UPC CFI 2566/2026Genevant Sciences GmbH v Pfizer, Inc.
  • 2025-07-03UPC CFI 620/2025GlaxoSmithKline Biologicals SA v C.P. Pharmaceuticals International C.V.
  • 2025-07-03UPC CFI 621/2025GlaxoSmithKline Biologicals SA v C.P. Pharmaceuticals International C.V.
  • —UPC APP 29243/2025Promosome LLC v BioNTech SE

More cases: Munich LD·2026